General Goal: To know the major cause(s) of these diseases, how they are transmitted, and the major manifestations of each disease.
Specific Educational Objectives: The student should be able to:
1. recite the common cause(s) of these disease.
2. describe the common means of transmission.
3. describe the major manifestations of this infection.
4. describe how you diagnose, treat and prevent this infection.
Reading: MEDICAL MICROBIOLOGY by P.R. Murray, K.S. Rosenthal, G.S. Kobayashi and M.A. Pfaller, 3rd Edition. page number depends on microorganism.
Mosby's Color Atlas and Text of Infectious Diseases by Christopher P. Conlon and David R. Snydman. pp.125-132.
Lecture: Dr. Neal R. Chamberlain
References:
The UTI Zone; Medscape.
R. ORENSTEIN and E. S. WONG. Urinary Tract Infections in Adults. American Family Physician. March 1, 1999.
Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;38:1150-1158.
UTI is defined as a significant bacteriuria in the presence of symptoms. The bacteria most often seen in UTIs are of fecal origin. These organisms are a subset of the organisms found in the feces. Strict anaerobic bacteria rarely cause UTIs. More than 90% of acute UTIs in patients with normal anatomic structure and function are caused by certain strains of E. coli. 10 to 20 percent are caused by coagulase-negative Staphylococcus saprophyticus and 5 percent or less are caused by other enterobacteriaceae organisms or enterococci. In complicated cases of UTI, such as UTI's resulting from anatomic obstructions, or from catheterization the most common causes of UTI are E. coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus sp., Pseudomonas aeruginosa. In rare cases Candida albicans can cause UTI (ex. diabetic patients). S. saprophyticus is the second most common cause in young sexually active women.
Outpatients
(%)Inpatients
(%)Escherichia coli 53-72 18-57 Coagulase negative Staphylococcus 2-8 2-13 Klebsiella 6-12 6-15 Proteus 4-6 4-8 Morganella 3-4 5-6 Enterococcus 2-12 7-16 Staphylococcus aureus 2 2-4 Staphylococcus saprophyticus 0-2 0.4 Pseudomonas 0-4 1-11 Candida 3-8 2-26
Males experience a rapid increase in the incidence UTI's sometime in their 40s. This is about the time that males are experiencing prostate gland hypertrophy. Women generally don't have many problems with UTI's until they become sexually active.
Risk factors:
B. Host factors - Host factors important in protection from cystitis include the normal flow of urine and the constant sloughing of the epithelial cells lining the urinary tract. The kidneys are protected due to the presence of the ureterovesical valves that prevent reflux of urine from the bladder, and constant peristalsis of the ureters.
The larger number of UTI's present in women than in men is probably due to the much shorter urethra and the much closer association of the urethra to the anus. Sexual intercourse contributes to the increased number of UTI's seen in women. Celibate women have a lower frequency of bacteriuria.
Some women have been shown to have a much higher number of bacterial receptors on their uroepithelial cells leading to recurrent UTIs. Also, any anatomic obstruction, or neurological disorder leading to the failure to completely eliminate the urine can lead to UTI. Men in their 40's have problems with the prostate gland enlarging resulting in obstruction of the urethra followed by incomplete elimination of urine from the bladder and UTI's.
C. Bacterial factors - The ability of an organism to produce pili is important in that it enables the bacteria to attach to the epithelial cells and thereby avoid elimination. Damage to the kidney appears to result from the ability of the organism to produce polysaccharide which inhibits phagocytosis, hemolysins that can cause tissue damage directly, and endotoxin from Gram negative organisms that appear to contribute to inflammation and damage of renal parenchyma.
D. Spread to the kidney - Infection of the kidney is due to ascent from the lower urinary tract and so any factor leading to retrograde flow of the urine to the kidney will predispose the host to pyelonephritis. Such factors include:
A. Urethritis - Most of the cases of purulent urethritis without cystitis are sexually transmitted and will be discussed later. the inflammation and infection is limited to the urethra. It is usually sexually transmitted. Pathogens such as Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, or Trichomonas vaginalis are the common causes of urethritis. Found in men and women, complaints include discomfort during voiding, but there are usually no symptoms of postvoid suprapubic pain or urinary frequency.
B. Cystitis - Results from an irritation of the lower urinary tract mucosa. This infection as such is not invasive. Frequently, one will see:
Symptoms 1-4 are sometimes called irritative voiding symptoms.
C. Hemorrhagic cystitis is characterized by large quantities of visible blood in the urine. It can be caused by an infection (bacterial or adenovirus types 1-47) or as a result of radiation, cancer chemotherapy, or select immunosuppressive medication. Clinical presentation usually depends on its origin. All causes result in irritative voiding symptoms typically. When infectious in origin, signs and symptoms of infection may also be encountered. Adenovirus is a common cause and is self-limiting in nature. Hemorrhagic cystitis is often confused with glomerulonephritis, but hypertension and abnormal renal function are absent in hemorrhagic cystitis. Hemorrhagic cystitis may develop months after cessation of radiation therapy.D. Pyelonephritis - This infection usually results from ascension of the bacteria to the kidney from the lower urinary tract, but also can arise by hematogenous spread (ex. from lungs in patients with pneumonia). In contrast to cystitis, pyelonephritis is an invasive disease. Blood cultures are positive in up to 20 percent of women who have this infection. Unfortunately, despite appropriate intervention, 1-3% of patients with acute pyelonephritis die. Symptoms in addition to those seen in cystitis are:
Since very few organisms cause UTI in acute uncomplicated cystitis in young women and since their antibiotic sensitivity is relatively predictable, urine cultures and susceptibility testing add little to the choice of antibiotic. Therefore, urine cultures are no longer advocated as part of the routine work-up of these patients. Instead, these patients should undergo an abbreviated laboratory work-up in which the presence of pyuria is confirmed by traditional urinalysis (wet mount examination of spun urine), the cell-counting chamber technique (looking for more than 8 white blood cells per mm3) or a dipstick test for leukocyte esterase. A positive leukocyte esterase test has a reported sensitivity of 75 to 90 percent in detecting pyuria associated with a UTI.
Gram staining unspun urine can be used to detect bacteriuria. In this semiquantitative test, one organism per oil immersion field correlates with 100,000 CFU per mL by culture. Because the procedure is time-consuming and has low sensitivity, it is not routinely performed in most clinical laboratories unless it is specifically requested.
In today's office practice, the dipstick test for nitrite is used as
a surrogate marker for bacteriuria. It should be noted that not all uropathogens
reduce nitrates to nitrite. For example, enterococci, S. saprophyticus
and Acinetobacter species do not and therefore give false-negative
results.
| TABLE
1
Urinary Tract Infections in Adults |
||||
| Category
|
Diagnostic
criteria
|
Principal
pathogens
|
First-line
therapy
|
Comments
|
| Acute uncomplicated cystitis | Urinalysis for pyuria, bacteriuria and hematuria (culture not required) | Escherichia
coli
Staphylococcus saprophyticus Proteus mirabilis Klebsiella pneumoniae |
TMP-SMX DS (Bactrim,
Septra)
Trimethoprim (Proloprim) Ciprofloxacin (Cipro) Ofloxacin (Floxin) |
Three-day course
is best
Quinolones may be used in areas of TMP-SMX resistance or in patients who cannot tolerate TMP-SMX |
| Recurrent cystitis in young women | Symptoms and a urine culture with a bacterial count of more than 100 CFU per mL of urine | Same as for acute uncomplicated cystitis | If the patient has more than three cystitis episodes per year, treat prophylactically with postcoital, patient- directed* or continuous daily therapy | Repeat therapy for seven to 10 days based on culture results and then use prophylactic therapy |
| Acute cystitis in young men | Urine culture with a bacterial count of 1,000 to 10,000 CFU per mL of urine | Same as for acute uncomplicated cystitis | Same as for acute uncomplicated cystitis | Treat for seven to 10 days |
| Acute uncomplicated pyelonephritis | Urine culture with a bacterial count of 10,000 CFU per mL of urine | Same as for acute uncomplicated cystitis | If gram-neg
organism, oral fluoroquinolone.
If gram-pos organism, amoxicillin. If parenteral administration is required, ceftriaxone (Rocephin) or a fluoroquinolone. If Enterococcus species, add oral or IV amoxicillin |
Switch from IV to oral administration when the patient is able to take medication by mouth; complete a 14-day course |
| Complicated urinary tract infection | Urine culture with a bacterial count of more than 10,000 CFU per mL of urine | E. coli
K. pneumoniae P. mirabilis Enterococcus species Pseudomonas aeruginosa |
If gram-negative
organism, oral fluoroquinolone.
If Enterococcus species, ampicillin or amoxicillin with or without gentamicin (Garamycin). |
Treat for 10 to 14 days |
| Asymptomatic bacteriuria in pregnancy | Urine culture with a bacterial count of more than 10,000 CFU per mL of urine | Same as for acute uncomplicated cystitis | Amoxicillin
Nitrofurantoin (Macrodantin) Cephalexin (Keflex) |
Avoid tetracyclines
and fluoroquinolones.
Treat for three to seven days |
| Catheter-associated urinary tract infection | Symptoms and a urine culture with a bacterial count of more than 100 CFU per mL of urine | Depends on duration of catheterization | If gram-negative
organism, a fluoroquinolone.
If gram-positive organism, ampicillin or amoxicillin plus gentamicin. |
Remove catheter
if possible, and treat for seven to 10 days.
For patients with long-term catheters and symptoms, treat for five to seven days |
|
TMP-SMX=trimethoprim-sulfamethoxazole; CFU=colony-forming unit; IV=intravenous. *--Patient is given a prescription for an antibiotic to take if symptoms develop. Information from Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34. |
||||
If culture of the urine is required it must be done using a mid-stream catch (clean catch specimen). If the patient can't or won't comply, use percutaneous bladder aspiration or ureter catheterization. Bacteria grow rapidly in urine therefore urine samples should be processed immediately or refrigerated. Cultures refrigerated for more than 2 hours are no good.
Methods to establish bacteriuria:
2. Quantitative loop method:
4. Chemical tests using dip sticks coated with specific chemicals and/or substrates; simply dip the sticks in urine and look for color changes in a few minutes.
5. Automated technology to detect bacteriuria:
There are a number of tests to establish the site of infection.
Between 10 and 20 percent of patients who are hospitalized receive an indwelling Foley catheter. Once this catheter is in place, the risk of bacteriuria is approximately 5 percent per day. With long-term catheterization, bacteriuria is inevitable. Catheter-associated urinary tract infections account for 40 percent of all nosocomial infections and are the most common source of gram-negative bacteremia in hospitalized patients.
Asymptomatic bacteriuria is defined as the presence of more than 100,000 CFU per mL of voided urine in persons with no symptoms of urinary tract infection. The largest patient population at risk for asymptomatic bacteriuria is the elderly. Up to 40 percent of elderly men and women may have bacteriuria without symptoms. Aggressively screening elderly persons for asymptomatic bacteriuria and subsequent treatment of the infection has not been found to reduce either infectious complications or mortality. Consequently, this approach currently is not recommended.
Three groups of patients with asymptomatic bacteriuria have been shown to benefit from treatment:
|
|
![]() |
A. The clinical manifestations determine the initial step in therapy.
1. Uncomplicated symptomatic acute cystitis and/or urethritis are usually treated for three days with trimethoprim-sulfamethoxazole (TMP-SMX), norfloxacin, or ciprofloxacin.
2. Pyelonephritis is more difficult to cure than urethritis-cystitis and reoccurrence due to relapse (i.e. treatment failure) or reinfection is more common.
4. Single-dose antibiotic therapy fell into disfavor when it was observed that women had a high risk of recurrence within six weeks of the initial treatment. The risk was attributed to the failure of single-dose antibiotics to eradicate gram-negative bacteria from the rectum, the source or reservoir for ascending uropathogens.
5. Women who have more than three UTI recurrences documented by urine culture within one year can be managed using one of three preventive strategies:
6. Complicated UTI's occur because of anatomic, functional or pharmacologic factors that predispose the patient to persistent infection, recurrent infection or treatment failure. These factors include conditions often encountered in elderly men, such as enlargement of the prostate gland, blockages and other problems necessitating the placement of indwelling urinary devices, and the presence of bacteria that are resistant to multiple antibiotics. Although antibiotic-susceptible E. coli strains are responsible for more than 80 percent of uncomplicated UTI's, it accounts for fewer than 33% of complicated cases. Clinically, the spectrum of complicated UTI's may range from cystitis to urosepsis with septic shock.
If the patient has a urinary tract infection urge them to:
A large number of pregnant women develop asymptomatic bacteriuria. Up to 30% of pregnant women with asymptomatic bacteriuria will develop acute pyelonephritis if not treated. Asymptomatic bacteriuria may also have a role in preterm birth, or it may be a marker for low socioeconomic status and thus, low birthweight. Drug treatment of asymptomatic bacteriuria in pregnant women substantially decreases the risk of pyelonephritis. Urine samples should be obtained periodically from pregnant women to determine if they have bacteriuria.
Vaginal Vaccine Curbs Urinary Tract Infections (Urovac)
Repeated
immunization with a vaginal mucosal vaccine increases the time to re-infection
in women susceptible to urinary tract infections (UTIs), researchers report in
the September issue of the Journal of Urology. In fact, as lead investigator Dr.
David T. Uehling told Reuters Health, "women receiving 6 doses of the
vaccine remained infection-free significantly longer than patients receiving 3
doses or placebo only."
The
researchers conducted a double-blind phase 2 trial of suppositories containing
Urovac, a vaginal vaccine containing 10 heat-killed uropathogens. There were
significantly fewer uti’s in women given the vaccine than in the control
groups.
Dr.
Uehling said that the findings "set the stage for a phase 3 clinical trial
involving other medical centers and we are currently seeking a pharmaceutical
sponsor."